Title of article :
Degrees of Kidney Disease in Nigerian Adults with Sickle-Cell Disease
Author/Authors :
Aneke, John C. Nnamdi Azikiwe University - Nnamdi Azikiwe University Teaching Hospital - Department of Haematology, Nigeria , Adegoke, Adegbola O. Obafemi Awolowo University Teaching Hospital - Department of Chemical Pathology, Nigeria , Oyekunle, Anthony A. Obafemi Awolowo University Teaching Hospital - Department of Haematology, Nigeria , Osho, Patrick O. Obafemi Awolowo University Teaching Hospital - Department of Haematology, Nigeria , Sanusi, Abubakra A. Obafemi Awolowo University Teaching Hospital - Department of Medicine, Nigeria , Okocha, Emmanuel C. Nnamdi Azikiwe University - Nnamdi Azikiwe University Teaching Hospital - Department of Haematology, Nigeria , Ibeh, Nancy C. Nnamdi Azikiwe University - Department of Medical, Laboratory Science, Nigeria , Akinola, Norah O. Obafemi Awolowo University Teaching Hospital - Department of Haematology, Nigeria , Durosinmi, Muheez A. Obafemi Awolowo University Teaching Hospital - Department of Haematology, Nigeria
Abstract :
Objective: To study degrees of chronic kidney disease (CKD) using creatinine clearance in adult Nigerian patients with sickle-cell disease (SCD). Methods: One hundred SCD patients, made up of 79 HbSS (homozygous haemoglobin S) patients and 21 HbSC (heterozygous haemoglobins S and C) patients, were investigated prospectively, along with 50 normal controls. Their sociodemographic data, weight and drug history were documented. Each participant underwent dipstick urinalysis, and creatinine clearance was calculated following a 24-hour urine collection and serum creatinine measurement. They were categorized into stages of CKD based on the creatinine clearance. Results: Of the 79 HbSS patients, 14 (18%), 28 (35%), 33 (42%) and 4 (5%) had stage 1, 2, 3 and 4 CKD, respectively. In the HbSC group, 3 (14%), 9 (43%) and 9 (43%) patients had stage 1, 2 and 3 CKD, respectively. Proteinuria was noted in 16 (20%) HbSS patients but not in any of the HbSC patients. Of the subjects aged ≤ 24 years (n = 49), 9 (18%), 18 (37%), 21 (43%) and 1 (2%) had stage 1, 2, 3 and 4 CKD, respectively. Of those aged 24 years (n = 51), 8 (16%), 19 (37%), 21 (41%) and 3 (6%) had stage 1, 2, 3 and 4 CKD, respectively. None of the subjects had stage 5 CKD. Conclusion: In this study, the adult subjects with SCD had various degrees of CKD. Adequate follow-up and active intervention are advocated to delay the onset of end-stage nephropathy.
Keywords :
Chronic kidney disease · Creatinine clearance · Sickle , cell disease
Journal title :
Medical Principles and Practice
Journal title :
Medical Principles and Practice